Vivos Therapeutics, Inc.

VVOS ·Healthcare, Medical Devices, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K/A Sep 8, 2026 8-K/A
8-K Sep 8, 2026 8-K
SCHEDULE 13G/A Sep 3, 2026
4 Aug 26, 2026 4
8-K Aug 21, 2026 8-K
10-Q Aug 14, 2026 10-Q
SCHEDULE 13G/A Aug 14, 2026
8-K Aug 11, 2026 8-K
SCHEDULE 13G Aug 11, 2026
8-K Aug 3, 2026 8-K
SCHEDULE 13D Jul 15, 2026
4 Jul 15, 2026 4
3 Jul 15, 2026 3
8-K Jul 7, 2026 8-K
8-K Jun 25, 2026 8-K
8-K Jun 16, 2026 8-K
8-K Jun 16, 2026 8-K
8-K Jun 8, 2026 8-K
10-Q May 20, 2026 10-Q
NT 10-Q May 15, 2026 NT 10-Q
SCHEDULE 13G May 15, 2026
EFFECT May 8, 2026
424B3 May 8, 2026 424B3
CORRESP May 6, 2026
S-3/A Apr 30, 2026 S-3/A
← Newer Page 1 of 12 · 287 filings Older →